KPV: Clinical Mechanism, Dossier & Protocols
Naturally occurring C-terminal tripeptide fragment of alpha-Melanocyte-Stimulating Hormone (alpha-MSH) with potent anti-inflammatory, antimicrobial, and gut barrier restorative actions without pigment changes.
🔬 Molecular Architecture & Physical Specifications
⚙️ Primary Mechanism of Action
Enters the cell nucleus to directly inhibit NF-kappaB translocation and downregulate proinflammatory cytokines (IL-1beta, IL-6, TNF-alpha) and exhibits antimicrobial activity against Candida albicans and S. aureus.
💉 Research Dosage & Reconstitution Standard
Requires pharmaceutical-grade 0.9% benzyl alcohol Bacteriostatic Water to inhibit bacterial replication for multi-dose access.
⚠️ Contraindications & Documented Adverse Effects
Strict Contraindications
- None known
Documented Side Effects
- Minimal to none observed; very high tolerability profile
📚 Peer-Reviewed References & Authoritative Sources
Citations indexed in PubMed, National Center for Biotechnology Information (NCBI), and ClinicalTrials.gov.
Explore Related Research Modules
Access exact dilution guides, syringe unit calculators, and purity certificates for KPV.